{"id":"W3170130315","doi":"10.1200/jco.2021.39.15_suppl.10009","title":"Oral selpercatinib in pediatric patients (pts) with advanced <i>RET</i>-altered solid or primary CNS tumors: Preliminary results from the phase 1/2 LIBRETTO-121 trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Medullary thyroid cancer; Vandetanib; Internal medicine; Cancer; Oncology; Thyroid cancer; Papillary thyroid cancer; Dosing; Phases of clinical research; Chemotherapy; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005753154,0.0006572611,0.0008014693,0.0001553475,0.0001552711,0.0004971267,0.0003006697,0.000438551,0.002197095],"category_scores_gemma":[0.0004707811,0.0001631526,0.0005606458,0.000329031,0.0002753006,0.0005311706,0.0002328386,0.001276549,0.0003903541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007001067,"about_ca_system_score_gemma":0.001134047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001406216,"about_ca_topic_score_gemma":0.006381777,"domain_scores_codex":[0.9998769,0.00005484047,0.000009094916,0.0000184064,0.0000160973,0.000024764],"domain_scores_gemma":[0.9996762,0.00006180879,0.0000790413,0.0000112545,0.00002448896,0.0001472526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3572702,0.02267945,0.07756866,0.002884259,0.002373855,0.001829122,0.0007222738,0.00690458,0.04138568,0.0007674078,0.03815545,0.4474591],"study_design_scores_gemma":[0.3681996,0.4023713,0.158458,0.0005216647,0.002736658,0.005663861,0.0004378372,0.005246807,0.01263284,0.0006778634,0.04296944,0.00008421079],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98665,0.00673756,0.0003123235,0.0006611838,0.00004957224,0.0005309849,0.002308639,0.00006591198,0.002683805],"genre_scores_gemma":[0.9776134,0.008892979,0.001608225,0.001047303,0.0001138619,0.0008356962,0.007854125,0.00003624075,0.00199826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002197095,"threshold_uncertainty_score":0.007349968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09927461659817029,"score_gpt":0.441816070338597,"score_spread":0.3425414537404268,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}